President and Director: John A. Taylor III, MD, MS, is a urologic oncologist whose practice and research are focused on bladder cancer. He received his medical degree from Columbia University where he also did his urological training. He obtained a masters degree in Clinical & Translational Science from the University of Connecticut. His work has been funded by the American Cancer Society, American Urological Association, American Geriatrics Society and the Connecticut Institute for Clinical and Translational Science.
Secretary: Jackie L. Canyon III, Esq., is Special Counsel at Sussman Shank LLP and a member of the firm’s Health Care Group and Business Group. He focuses his practice on health care law and all areas of corporate transactions. Jackie is a seasoned health law attorney, with over 18 years experience serving in various in-house, senior-level legal positions within the health care industry.
Gene Pranzo, Esq., is the trustee for The Albert Charitable Trust and CEO and president of The Dorothy R. Havemeyer Foundation. He was instrumental in developing the Foundation from its inception in 1979 to its role in scientific research, workshops and publications.
Carolyn D. Runowicz, MD, is currently the Executive Associate Dean for Academic Affairs at the Herbert Wertheim College of Medicine of Florida International University. She was the first women president of the Society of Gynecology-Oncology and is a past president of the American Cancer Society. She has served on the National Cancer Advisory Board (appointed by President Bush) and was chair for four years. She is currently on the Board of Directors of the American Society of Clinical Oncology and serves on multiple scientific advisory boards including the NCI.
Scott Weir, PharmD, PhD, is a genitourinary medical oncologist with focus on bladder. She received her medical degree from the Virginia Commonwealth University School of Medicine and did her residency training and fellowship at the Beth Israel Deaconess Medical Center in Boston. Her research focus is bladder cancer with particular interest in clinical trials.